Identification of TIMP2 as a Prognostic Biomarker and Its Correlation with Tumor Immune Microenvironment: A...

Area of Science:

• Oncology
• Bioinformatics
• Cancer Research

Background:

• Tissue inhibitor of metalloproteinase-2 (TIMP2) is implicated in cancer development.
• The prognostic value and tumor microenvironment correlations of TIMP2 remain unclear across various cancers.

Purpose of the Study:

• To comprehensively analyze the prognostic and therapeutic potential of TIMP2 in cancer patients.
• To investigate the relationship between TIMP2 expression and tumor immune microenvironment characteristics.

Main Methods:

• Utilized bioinformatics databases (Oncomine, GEPIA, cBioPortal, GeneMANIA, Metascape, Sangerbox) for expression, mutation, and survival analyses.
• Explored protein-protein interactions within the TIMP family.
• Assessed correlations between TIMP2 and immune markers, tumor mutational burden (TMB), and microsatellite instability (MSI).

Main Results:

• TIMP2 transcriptional levels were significantly increased in most cancer tissues.
• Elevated TIMP2 expression was linked to unfavorable survival outcomes in multiple cancers.
• Enrichment analysis highlighted TIMP2's involvement in extracellular matrix regulation and degradation pathways.

Conclusions:

• TIMP2 serves as a potential prognostic biomarker across diverse cancers.
• TIMP2 inhibition presents a promising therapeutic strategy for improving cancer survival and prognostic accuracy.
• Further experimental validation is required to elucidate the precise mechanisms of TIMP2 in cancer therapy.